Myomo (MYO) Gross Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,159.00 |
| Jun 30, 2025 | -811.00 |
| Mar 31, 2025 | 599.00 |
| Dec 31, 2024 | 611.00 |
| Sep 30, 2024 | 675.00 |
| Jun 30, 2024 | -104.00 |
| Mar 31, 2024 | -572.00 |
| Dec 31, 2023 | 26.00 |
| Sep 30, 2023 | 223.00 |
| Jun 30, 2023 | 656.00 |
| Mar 31, 2023 | 32.00 |
| Dec 31, 2022 | -1,243.00 |
| Sep 30, 2022 | -822.00 |
| Jun 30, 2022 | -567.00 |
| Mar 31, 2022 | -670.00 |
| Dec 31, 2021 | 403.00 |
| Sep 30, 2021 | 1,907.00 |
| Jun 30, 2021 | 1,974.00 |
| Mar 31, 2021 | 494.00 |
| Dec 31, 2020 | 134.00 |
| Sep 30, 2020 | 988.00 |
| Jun 30, 2020 | -561.00 |
| Mar 31, 2020 | 294.00 |
| Dec 31, 2019 | -250.00 |
| Sep 30, 2019 | -2,249.00 |
| Jun 30, 2019 | -1,148.00 |
| Mar 31, 2019 | -4.00 |
| Dec 31, 2018 | -36,777.00 |
| Sep 30, 2018 | -639.00 |
| Jun 30, 2018 | 47.00 |
| Mar 31, 2018 | -67,863.00 |
| Dec 31, 2017 | 36,374.00 |
| Sep 30, 2017 | 1,645.00 |
| Jun 30, 2017 | -1,241.00 |